Dermatologic Adverse Events from Cancer Treatments

    October 2018 in “ Springer eBooks ”
    Jennifer Wu, Alina Markova, Mario E. Lacouture
    Studysummary Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 19

    1. Permanent Alopecia in Patients with Breast Cancer After Taxane Chemotherapy and Adjuvant Hormonal Therapy: Clinicopathologic Findings in a Cohort of 10 Patients Journal of The American Academy of Dermatology · 2017
    2. Janus Kinase Inhibitors in Dermatology: A Systematic Review Journal of the American Academy of Dermatology · 2017
    3. JAK Inhibitors in Dermatology: The Promise of a New Drug Class Journal of the American Academy of Dermatology · 2017
    4. Dermatological Adverse Events with Taxane Chemotherapy European Journal of Dermatology · 2016
    5. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma ˜The œoncologist · 2016
    6. Differential Diagnosis of Female-Pattern Hair Loss Skin appendage disorders · 2016
    7. Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies Annals of Oncology · 2015
    8. Management of Dermatologic Toxicities Journal of the National Comprehensive Cancer Network · 2015
    9. Dermatologic Adverse Events in Pediatric Patients Receiving Targeted Anticancer Therapies: A Pooled Analysis Pediatric blood & cancer · 2015
    10. Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial British journal of dermatology/British journal of dermatology, Supplement · 2014
    11. Efficacy and Tolerability of Two Scalp Cooling Systems for the Prevention of Alopecia Associated with Docetaxel Treatment Supportive Care in Cancer · 2013
    12. Dermatologic Adverse Events Associated With Afatinib: An Oral ErbB Family Blocker Expert Review of Anticancer Therapy · 2013
    13. Hair Shaft Abnormalities After Chemotherapy and Tamoxifen Therapy in Patients With Breast Cancer Evaluated by Optical Coherence Tomography British Journal of Dermatology · 2012
    14. Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy by Sequential Fluorouracil/Epirubicin/Cyclophosphamide (FEC) and Docetaxel: A Prospective Study of 20 Patients Annals of Oncology · 2012
    15. Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases The American Journal of Dermatopathology · 2011
    16. Permanent Chemotherapy-Induced Alopecia: Case Report and Review of the Literature Journal of The American Academy of Dermatology · 2010
    17. Irreversible And Severe Alopecia Following Docetaxel Or Paclitaxel Cytotoxic Therapy For Breast Cancer British journal of dermatology/British journal of dermatology, Supplement · 2009
    18. Chemotherapy-Induced Dermatological Toxicity: Frequencies and Impact on Quality of Life in Women’s Cancers. Results of a Prospective Study Supportive care in cancer · 2007
    19. Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned? Dermatology · 2007